Retrospective Study
Copyright ©The Author(s) 2016.
World J Clin Oncol. Dec 10, 2016; 7(6): 433-440
Published online Dec 10, 2016. doi: 10.5306/wjco.v7.i6.433
Figure 3
Figure 3 Cancer specific survival. A: Circulating CK+ cell negative vs positive; B: Circulating CK+ cell cluster negative vs positive; C: Tumor budding negative/low grade vs high grade. CK+: Cytokeratin-positive.